RNAi-based Small Molecule Repositioning Reveals Clinically Approved Urea-Based Kinase Inhibitors as Broadly Active Antivirals
PLoS Pathogens - United States
doi 10.1371/journal.ppat.1007601
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2019
Authors
Publisher
Public Library of Science (PLoS)